Janus Henderson Group PLC Rocket Pharmaceuticals, Inc. Transaction History
Janus Henderson Group PLC
- $178 Billion
- Q1 2024
A detailed history of Janus Henderson Group PLC transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 2,606,016 shares of RCKT stock, worth $55.6 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
2,606,016
Previous 949,905
174.34%
Holding current value
$55.6 Million
Previous $28.5 Million
146.61%
% of portfolio
0.04%
Previous 0.02%
Shares
15 transactions
Others Institutions Holding RCKT
# of Institutions
206Shares Held
92.9MCall Options Held
341KPut Options Held
107K-
Rtw Investments, LP New York, NY17.7MShares$377 Million7.65% of portfolio
-
Wellington Management Group LLP Boston, MA9.16MShares$195 Million0.04% of portfolio
-
Black Rock Inc. New York, NY5.93MShares$126 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.37MShares$115 Million0.0% of portfolio
-
State Street Corp Boston, MA4.19MShares$89.4 Million0.01% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $1.61B
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...